Annandale Capital’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,000
| Closed | -$122K | – | 130 |
|
|
2023
Q4 | $122K | Hold |
12,000
| – | – | 0.02% | 127 |
|
|
2023
Q3 | $109K | Buy |
12,000
+2,000
| +20% | +$18.2K | 0.03% | 120 |
|
|
2023
Q2 | $108K | Hold |
10,000
| – | – | 0.03% | 125 |
|
|
2023
Q1 | $102K | Hold |
10,000
| – | – | 0.03% | 122 |
|
|
2022
Q4 | $106K | Hold |
10,000
| – | – | 0.03% | 123 |
|
|
2022
Q3 | $128K | Buy |
+10,000
| New | +$128K | 0.05% | 123 |
|